Atara Biotherapeutics, Inc. (ATRA)
NASDAQ: ATRA · Real-Time Price · USD
9.73
+0.27 (2.85%)
Aug 25, 2026, 1:57 PM EDT - Market open

Atara Biotherapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
3.228.4825.0325.8492.94106.08
Short-Term Investments
6.65-17.4725.88149.88264.98
Cash & Short-Term Investments
9.878.4842.551.73242.82371.07
Cash Growth
-55.77%-80.04%-17.84%-78.70%-34.56%-25.88%
Accounts Receivable
0.321.251.4834.1140.220.99
Other Receivables
----0.80.8
Receivables
0.321.251.4834.1141.021.79
Inventory
--10.669.711.59-
Restricted Cash
--0.150.150.150.19
Other Current Assets
3.342.4810.126.189.5111.57
Total Current Assets
13.5312.2164.89101.87295.08384.62
Property, Plant & Equipment
6.737.1441.158.7974.3279.94
Other Long-Term Assets
0.770.893.14.847.023.57
Total Assets
21.0220.24109.1165.5376.42468.13

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
0.820.134.373.686.8717.37
Accrued Expenses
3.123.320.8248.5350.4144.91
Current Portion of Leases
1.11.0313.9212.1813.642.75
Current Unearned Revenue
1.8110.4795.4777.83840.76
Total Current Liabilities
6.8514.92134.57142.2378.92105.79
Long-Term Leases
8.789.3529.9145.6958.0625.52
Long-Term Unearned Revenue
40.5132.6738.6272.19107.2455.71
Other Long-Term Liabilities
1.891.83.274.635.561.5
Total Liabilities
58.0258.74206.38264.74249.78188.51

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
000-0.010.01
Additional Paid-In Capital
1,9941,9831,9571,8701,8221,745
Retained Earnings
-2,031-2,022-2,055-1,969-1,693-1,465
Comprehensive Income & Other
-000.01-0.2-2.07-0.37
Shareholders' Equity
-37-38.5-97.28-99.23126.64279.61
Total Liabilities & Equity
21.0220.24109.1165.5376.42468.13

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
9.8810.3843.8357.8771.728.27
Net Cash (Debt)
-0.01-1.89-1.34-6.15171.12342.8
Net Cash Growth
-----50.08%-29.41%
Net Cash Per Share
-0.00-0.15-0.18-1.4541.9491.49
Filing Date Shares Outstanding
10.048.185.864.773.843.72
Total Common Shares Outstanding
9.447.325.864.263.843.67
Working Capital
6.68-2.71-69.68-40.36216.16278.84
Book Value Per Share
-3.92-5.26-16.60-23.3133.0076.25
Tangible Book Value
-37-38.5-97.28-99.23126.64279.61
Tangible Book Value Per Share
-3.92-5.26-16.60-23.3133.0076.25
Machinery
-0.2217.6718.6617.8226.05
Construction In Progress
---0.160.036.33
Leasehold Improvements
-0.070.930.90.8850.14
SEC Filings: 10-K · 10-Q